Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1212283

Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study


Matišić, Vid; Brlek, Petar; Molnar, Vilim; Pavelić, Eduard; Čemerin, Martin; Vrdoljak, Kristijan; Skelin, Andrea; Erceg, Damir; Moravek, Davor; Ivkošić, Ivana Erceg; Primorac, Dragan
Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study // Croatian Medical Journal, 63 (2022), 3; 257-264 doi:10.3325/cmj.2022.63.257 (podatak o recenziji nije dostupan, članak, znanstveni)


CROSBI ID: 1212283 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study
(Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study)

Autori
Matišić, Vid ; Brlek, Petar ; Molnar, Vilim ; Pavelić, Eduard ; Čemerin, Martin ; Vrdoljak, Kristijan ; Skelin, Andrea ; Erceg, Damir ; Moravek, Davor ; Ivkošić, Ivana Erceg ; Primorac, Dragan

Izvornik
Croatian Medical Journal (0353-9504) 63 (2022), 3; 257-264

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
pharmacogenomic, drug-gene pairs, genotype-based prescribing
(pharmacogenomic, drug-gene pairs, genotype-based prescribin)

Sažetak
Aim To assess the prevalence of actionable pharmacogenetic interventions in patients who underwent pharmacogenetic testing with a multi- gene panel. Methods We retrospectively reviewed single-center electronic health records. A total of 319 patients were enrolled who underwent pharmacogenomic testing with the RightMed test panel using TaqMan quantitative real-time PCR method and copy number variation analysis to determine the SNPs in the 27 target genes. Results Actionable drug-gene pairs were found in 235 (73.7%) patients. Relevant guidelines on genotype- based prescribing were available for 133 (56.7%) patients at the time of testing. Based on the patients' genotype, 139 (43.6%) patients were using at least one drug with significant pharmacogenetic interactions. Conclusion Two out of three patients had at least one drug- gene pair in their therapy. Further studies should assess the clinical effectiveness of integrating pharmacogenomic data into patients' electronic health records.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti, Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Medicinski fakultet, Split

Profili:

Avatar Url DAVOR MORAVEK (autor)

Avatar Url Dragan Primorac (autor)

Avatar Url Damir Erceg (autor)

Avatar Url Andrea Skelin (autor)

Avatar Url Vilim Molnar (autor)

Avatar Url Petar Brlek (autor)

Poveznice na cjeloviti tekst rada:

doi www.cmj.hr

Citiraj ovu publikaciju:

Matišić, Vid; Brlek, Petar; Molnar, Vilim; Pavelić, Eduard; Čemerin, Martin; Vrdoljak, Kristijan; Skelin, Andrea; Erceg, Damir; Moravek, Davor; Ivkošić, Ivana Erceg; Primorac, Dragan
Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study // Croatian Medical Journal, 63 (2022), 3; 257-264 doi:10.3325/cmj.2022.63.257 (podatak o recenziji nije dostupan, članak, znanstveni)
Matišić, V., Brlek, P., Molnar, V., Pavelić, E., Čemerin, M., Vrdoljak, K., Skelin, A., Erceg, D., Moravek, D., Ivkošić, I. & Primorac, D. (2022) Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study. Croatian Medical Journal, 63 (3), 257-264 doi:10.3325/cmj.2022.63.257.
@article{article, author = {Mati\v{s}i\'{c}, Vid and Brlek, Petar and Molnar, Vilim and Paveli\'{c}, Eduard and \v{C}emerin, Martin and Vrdoljak, Kristijan and Skelin, Andrea and Erceg, Damir and Moravek, Davor and Ivko\v{s}i\'{c}, Ivana Erceg and Primorac, Dragan}, year = {2022}, pages = {257-264}, DOI = {10.3325/cmj.2022.63.257}, keywords = {pharmacogenomic, drug-gene pairs, genotype-based prescribing}, journal = {Croatian Medical Journal}, doi = {10.3325/cmj.2022.63.257}, volume = {63}, number = {3}, issn = {0353-9504}, title = {Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study}, keyword = {pharmacogenomic, drug-gene pairs, genotype-based prescribing} }
@article{article, author = {Mati\v{s}i\'{c}, Vid and Brlek, Petar and Molnar, Vilim and Paveli\'{c}, Eduard and \v{C}emerin, Martin and Vrdoljak, Kristijan and Skelin, Andrea and Erceg, Damir and Moravek, Davor and Ivko\v{s}i\'{c}, Ivana Erceg and Primorac, Dragan}, year = {2022}, pages = {257-264}, DOI = {10.3325/cmj.2022.63.257}, keywords = {pharmacogenomic, drug-gene pairs, genotype-based prescribin}, journal = {Croatian Medical Journal}, doi = {10.3325/cmj.2022.63.257}, volume = {63}, number = {3}, issn = {0353-9504}, title = {Experience with comprehensive pharmacogenomic multi-gene panel in clinical practice: a retrospective single-center study}, keyword = {pharmacogenomic, drug-gene pairs, genotype-based prescribin} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font